Minimum Offer of Guaranteed Workshare Still Not Enough to Enforce Teaming Agreement
Client Alert | 1 min read | 08.31.20
In Futrend Tech., Inc. v. MicroHealth LLC, a Virginia state court considered “an all too familiar tale” of a government contractor attempting to enforce a teaming agreement, and once again refused to do so. This case involved an incumbent prime contractor, Futrend, who teamed with an 8(a) small business, MicroHealth, to bid on the follow-on contract set aside for 8(a) businesses. MicroHealth was ultimately awarded the contract, but the relationship between the parties broke down while negotiating a subcontract contemplated by their teaming agreement. Futrend brought suit against MicroHealth alleging, inter alia, breach of that agreement, which promised approximately 49% of the workshare under the awarded contract.
Citing the “well-settled” law in Virginia that contractual provisions that “merely set out agreements to negotiate future subcontracts” are unenforceable, the court refused to enforce the agreement. The court noted the parties’ acknowledgement that the “minimum offer” required under the agreement established a floor legal obligation, but found it to be “illusory and indefinite.” While the agreement “guaranteed” workshare of “approximately 49%” of the awarded contract, the court explained that the use of the word “approximate” indicated a degree of indefiniteness. Given these “uncertain” legal obligations, the court held that the teaming agreement was unenforceable. In addition to the breach of contract count, the court also rejected all other claims flowing from the teaming agreement, including breach of non-solicitation provision, tortious interference, misappropriation of trade secrets, conspiracy, and unjust enrichment.
Contacts
Insights
Client Alert | 3 min read | 06.30.25
The New EU “Pharma Package”: Preparing for the Trilogues
On June 4, 2025, after nearly two years of intense debate and negotiation between the 27 EU Member States, the Council of the European Union adopted its position on the proposed overhaul of the EU general pharmaceutical legislative framework known as the new Pharma Package.
Client Alert | 3 min read | 06.26.25
FDA Targets Gene Editing Clinical Trials in China and other “Hostile Countries”
Client Alert | 3 min read | 06.26.25
Client Alert | 4 min read | 06.26.25
Ninth Circuit Affirms that CIPA Only Applies to Third-Party Eavesdropping